Posted On: 01/24/2015 7:32:15 AM
Post# of 30015
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
Re: Daveludlow #15912
have to agree with you Risk - I suspect the decision making process at this juncture in time regarding how AMBS wishes to outright sell, farm-out, perform equity stake % sales, spin off, or a multitude of other considerations needs to be done in the best and highest use for 1.) LymPro itself, 2.) AMBS Dx Div., 3.) shareholders interests.
Which ever direction they proceed with now, it will act like a dye being cast, and may well affect any other larger revenue considerations down the road which might be too late at that time, due to revenue paths choosen earlier - kind of like the why accept x now when you can have xxx later.
They'll figure it out. However like a number here have already expressed, I would rather see an outright sale of LymPro and/or Dx division now then a spinn off where we recieve a dividend or addit. shares.
I suspect a hefty buy out of the Dx Div. would enable them to proceed with MANF and Phenoguard unencumbered buy much additional debt or more dilution to what has already beed experienced.
Which ever direction they proceed with now, it will act like a dye being cast, and may well affect any other larger revenue considerations down the road which might be too late at that time, due to revenue paths choosen earlier - kind of like the why accept x now when you can have xxx later.
They'll figure it out. However like a number here have already expressed, I would rather see an outright sale of LymPro and/or Dx division now then a spinn off where we recieve a dividend or addit. shares.
I suspect a hefty buy out of the Dx Div. would enable them to proceed with MANF and Phenoguard unencumbered buy much additional debt or more dilution to what has already beed experienced.
![](http://imageshack.com/a/img538/8392/UtqWr5.jpg)
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)